Skye Bioscience increases authorized common shares from 20M to 100M

Skye Bioscience, Inc.

Filed Certificate of Amendment on Nov 6, 2023, raising authorized common shares from 20,000,000 to 100,000,000.
No change to issued and outstanding shares; only affects potential future issuances.
Board unanimously approved; majority stockholders consented in writing in lieu of a special meeting.
Amendment provides additional flexibility for future capital raising or strategic transactions.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Skye Bioscience, Inc.: Increased authorized shares of common stock from 20,000,000 to 100,000,000 (effective 2023-11-06).

Change: charter amendment
Effective: 2023-11-06

Exact text from the filing

On November 6, 2023, Skye Bioscience, Inc., a Nevada corporation (the "Company") filed a Certificate of Amendment to the Company's Articles of Incorporation (the “Articles”), to amend Section 1 of Article IV of the Articles to increase the number of authorized shares of common stock from 20,000,000 to 100,000,000 (the “Charter Amendment”).

View on SEC.gov

245 governance changes filed in the last 30 days. Browse all governance changes →

Skye Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001516551-23-000083

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.